Molecular and Cellular Biology of Brain Tumors and Neuro-Oncology

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neuro-oncology".

Deadline for manuscript submissions: 30 November 2024 | Viewed by 161

Special Issue Editor


E-Mail Website
Guest Editor
1. Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE-HCPA), Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil
2. Department of Pharmacology, Institute for Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil
Interests: brain tumor; glioma; glioblastoma; neuroblastoma; medulloblastoma; growth factors; membrane receptors; epigenetics

Special Issue Information

Dear Colleagues,

Understanding the cellular and molecular processes underlying the origin and progression of brain tumors, as well as the mechanisms of resistance to treatment and metastasis, is crucial for the development of better diagnostic tools and molecularly targeted innovative therapies. Despite important advances made in brain tumor biology over recent years, prognosis remains dismal, and survivors suffer from long-term sequelae of cytotoxic chemotherapy, radiotherapy, and surgical interventions. In this Special Issue of Brain Sciences, the current state of knowledge on the biological basis of brain tumor types including gliomas, medulloblastoma, and ependymomas will be addressed, and the potential applications of this knowledge for the development of novel diagnostic and therapeutic strategies will be presented.

Dr. Rafael Roesler
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • glioma
  • medulloblastoma
  • ependymoma
  • brain cancer
  • central nervous system tumor
  • neuro-oncology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop